Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications
Johnson & Johnson MedTech's Varipulse PFA system has been linked to multiple reports of "neurovascular events" in patients. The company hopes to share more information in the days ahead.
Stryker acquires Inari Medical for $4.9B
Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.
‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors
Approximately 800,000 strokes occur each year in the United States alone. A majority of people survive, due in part to key advances in patient care over the years, but they often go forward without receiving the long-term help they need to recover and thrive.
Advancing AI for vascular surgery will require a commitment to data integrity
For artificial intelligence to truly transform care, the healthcare industry must address certain challenges. Jens Eldrup-Jorgensen, MD, a veteran vascular surgeon and member of the Society for Vascular Surgery, explains in a guest editorial.
Industry concerns over paclitaxel-coated devices may have put PAD patients at risk
Back in 2019, the FDA issued a warning about the use of paclitaxel-coated devices when treating peripheral artery disease. The agency took back that warning in 2023, but it appears to have made a significant impact on patient care.

Patients with pulmonary arterial hypertension benefit from sotatercept treatment

After 24 weeks, treatment with sotatercept was associated with a significant reduction in pulmonary vascular resistance.

April 5, 2021

The blood clot plot continues: Countries suspend use of AstraZeneca COVID-19 vaccine in younger adults

The ongoing saga continues. Both Germany and Canada have now limited the use of the AstraZeneca vaccine among younger adults.

March 30, 2021

Championing Alternative PAD Access in the Office-based Lab

Sponsored by Terumo

Improving access is at the center of a pair of new trends in treating peripheral artery disease (PAD). First is the office-based lab (OBL) expanding access to more PAD patients needing therapy, and the second is physicians more often choosing alternative access such as radial, tibial or pedal to treat those patients. Why now?

NOACs associated with a 16% lower risk of bone fractures than warfarin

These findings are especially important, the authors explained, because the number of elderly patients on OACs continues to rise.

March 24, 2021

AstraZeneca COVID-19 vaccine to get a blood clot warning in Canada

Officials confirmed, however, that they still believe the vaccine is safe and effective.

March 23, 2021

Mobile stroke units improve patient outcomes, reduce risk of disability

Researchers tracked data from more than 1,000 patients who received care from 2014 to 2020.

March 19, 2021

COVID-19 coronavirus burnout depression pandemic

‘Not just a respiratory illness’: New stroke data highlight the importance of COVID-19 vaccinations

COVID-19 carries a higher stroke risk than similar infectious conditions, the authors explained, making it especially important to seek out a vaccine as soon as possible.

March 19, 2021

Adding icosapent ethyl to statin therapy may reduce risk of stroke by 36%

Icosapent ethyl is an FDA-approved medication typically prescribed to limit triglycerides in the blood.

March 18, 2021

Vascular & Endovascular

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications

Stryker acquires Inari Medical for $4.9B

‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors

Advancing AI for vascular surgery will require a commitment to data integrity

Industry concerns over paclitaxel-coated devices may have put PAD patients at risk